HOME >> MEDICINE >> NEWS
New HIV guidelines support use of FUZEON + active boosted PI for treatment-experienced patients

Basel (CH), 14 October 2005. The importance of the drug FUZEON (enfuvirtide) in the management of HIV has been officially recognised by the US Department of Health and Human Services (DHHS). Their newly updated HIV/AIDS treatment guidelines support the use of FUZEON with an active boosted protease inhibitor (PI) for the management of treatment-experienced patients.

"These guidelines clearly set more ambitious goals for the management of treatment-experienced patients now that we have potent therapies such as the combination of tipranavir and enfuvirtide," commented Dr Anton Pozniak, Chelsea and Westminster Hospital, London. "These guidelines provide real clarity and much needed direction on how to best care for pre-treated patients."

The DHHS recommendation reflects the growing body of evidence for the powerful "FUZEON effect" which has been seen across the RESIST 1 & 2, POWER 1 & 2 and TORO 1 & 2 studies. These studies showed that adding FUZEON almost doubled the number of patients reaching undetectable, when combined with one of the latest boosted protease inhibitors (PI) such as lopinavir, tipranavir or TMC 114.

The guidelines recommend the treatment goal of achieving the suppression of the virus to levels that make it undetectable in the blood, for treatment-experienced patients who show some drug resistance but still have some active antiretroviral agents available. An active drug is one that is still effective against the virus.


'"/>

Contact: Laura Bertossi
laura.bertossi@ketchum.com
44-207-611-3597
Ketchum
14-Oct-2005


Page: 1

Related medicine news :

1. ACC/AHA release revised UA/NSTEMI guidelines
2. Quality of treatment guidelines
3. Medical residents unclear about TB guidelines
4. Emergency department guidelines enhance quality patient care
5. International journal group updates guidelines on registration of clinical trials
6. Panel offers guidelines on skin reactions to new class of cancer drugs
7. New prostate cancer clinical guidelines to be released
8. Clinical guidelines for blood conservation during cardiac procedures developed
9. New reflux guidelines released
10. Lack of guidelines on kidney stone attacks could put travel workers and passengers at risk
11. Cholesterol in stroke patients exceeds national guidelines

Post Your Comments:
(Date:7/31/2014)... Thousands of independent community pharmacists, industry ... come together today to kick off ThoughtSpot 2014, ... "ThoughtSpot 2014 is Good Neighbor Pharmacy’s annual conference ... help their businesses thrive," stated AJ Caffentzis, President, ... commitment to independent community pharmacies, and at ThoughtSpot, ...
(Date:7/31/2014)... San Francisco, California (PRWEB) July 31, 2014 ... systems is expected to reach USD 37.83 billion ... Grand View Research, Inc. Increasing geriatric population base ... such as cardiovascular, orthopedic, and respiratory diseases coupled ... drive market growth over the next six years. ...
(Date:7/31/2014)... By Steven Reinberg ... (HealthDay News) -- Strict regulation of electronic cigarettes isn,t ... says. On the contrary, allowing e-cigarettes to compete ... the researchers concluded after reviewing 81 prior studies on ... "Current evidence suggests that there is a ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 ... to reach $702m by 2020, increasing slowly ... market will be driven by: the rising ... incurred by government agencies, such as Medicare, ... adoption of innovative technologies such as flow ...
(Date:7/31/2014)... for those with periodontal disease related to type 2 diabetes, ... report appearing in the August 2014 issue of the ... most important blood cells involved in the human immune response, ... in type 2 diabetes-associated periodontal disease. These findings support ... cells may treat or prevent this complication. , "Our ...
Breaking Medicine News(10 mins):Health News:Good Neighbor Pharmacy’s ThoughtSpot Begins Today with Record Attendance 2Health News:Good Neighbor Pharmacy’s ThoughtSpot Begins Today with Record Attendance 3Health News:Medical Imaging Systems - Global Industry Trends, Size, Share, Opportunity, Growth, Outlook, Segmentation and Forecast from 2014 to 2020 - Grand View Research, Inc. 2Health News:Medical Imaging Systems - Global Industry Trends, Size, Share, Opportunity, Growth, Outlook, Segmentation and Forecast from 2014 to 2020 - Grand View Research, Inc. 3Health News:Medical Imaging Systems - Global Industry Trends, Size, Share, Opportunity, Growth, Outlook, Segmentation and Forecast from 2014 to 2020 - Grand View Research, Inc. 4Health News:Medical Imaging Systems - Global Industry Trends, Size, Share, Opportunity, Growth, Outlook, Segmentation and Forecast from 2014 to 2020 - Grand View Research, Inc. 5Health News:Medical Imaging Systems - Global Industry Trends, Size, Share, Opportunity, Growth, Outlook, Segmentation and Forecast from 2014 to 2020 - Grand View Research, Inc. 6Health News:Benefits of E-Cigarettes May Outweigh Harms, Study Finds 2Health News:Benefits of E-Cigarettes May Outweigh Harms, Study Finds 3Health News:US Neurovascular Interventions Market Worth $702m by 2020 Says a New Report Available at MarketOptimizer.org 2Health News:US Neurovascular Interventions Market Worth $702m by 2020 Says a New Report Available at MarketOptimizer.org 3Health News:US Neurovascular Interventions Market Worth $702m by 2020 Says a New Report Available at MarketOptimizer.org 4Health News:US Neurovascular Interventions Market Worth $702m by 2020 Says a New Report Available at MarketOptimizer.org 5Health News:Researchers uncover cause of gum disease related to type 2 diabetes 2
(Date:7/31/2014)... NOTTINGHAM, England , July 31, 2014 /PRNewswire/ ... ) today announced that its subsidiary, Molecular Profiles ... that will support pharmaceutical and biotech drug developers ... Profiles, pharmaceutical development services will be supported by ... (DMPK) to give clients a smarter route into ...
(Date:7/31/2014)... RESEARCH TRIANGLE PARK, N.C. , July 31, 2014 ... Miami facilities to meet the ... Latin America .  The newly expanded facility will ... biological samples, consolidation of shipments to and from the ... In its newest location, Marken will combine its ...
(Date:7/31/2014)... , July 31, 2014  Today,s Consumer Reports ... as an important reminder for consumers of the ... importance of initiatives such as the Acetaminophen Awareness ... consumer education campaign. Formed in 2010, the ... provider and consumer organizations dedicated to educating consumers ...
Breaking Medicine Technology:Columbia Laboratories' Subsidiary, Molecular Profiles, Strikes Alliance With Xenogesis 2Columbia Laboratories' Subsidiary, Molecular Profiles, Strikes Alliance With Xenogesis 3Marken Expands Miami Regional Logistics Center 2U.S. Health Coalition Calls for Continued Education on Acetaminophen, America's Most Common Drug Ingredient 2
Cached News: